Drawing for THINC-IT

USPTO serial 86850530

THINC-IT

Reviewed by CopyMark Law Group

Reg. 5299026Status 710
Filing date
Status date
Registration date
Oct 3, 2017
Examiner
PEREZ, STEVEN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with THINC-IT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia A. Smith

CLAUDIA A. SMITH WHITE & CASE LLP1221 AVENUE OF THE AMERICASTRADEMARK DEPARTMENTNEW YORK, NY 10020

Goods and services

ClassDescriptionStatusFirst use
005Vaccines; pharmaceutical preparations and substances for the treatment and prevention of brain and nerve diseases and disorders, sanitary preparations for medical purposes; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorder, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcohol dependence; diagnostic agents, reagents, preparations and substances for medical purposes; pharmaceutical preparations for the treatment of cognitive disordersSECTION 8 - CANCELLED—
009Downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, and teaching and educational manuals and textbooks all in the field of medical and pharmaceutical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, and for the treatment and prevention of central nervous system diseases and disorders thereof; application software for mobile devices, namely, database management software for use in providing medical and pharmaceutical information to users in the context of education activities; application software for mobile devices for the assessment of cognitive functions; downloadable software applications for the assessment of cognitive functions all for managing patient medical information and interactionSECTION 8 - CANCELLED—
010Medical diagnostic apparatus and instruments, namely, test kits for the detection of brain and nerve diseases and disorders; integrated medical examination systems comprised primarily of medical instruments for central nervous system related diagnostics, and also containing computer hardware and software for information management, for use in web-based physical, psychological, and neurological examination and assessment of patients at a distance and in person in clinical settings; medical instruments for providing information, guidance, and control of medicines, namely, drug delivery systemsSECTION 8 - CANCELLED—
041Education, namely, providing continuing medical education courses; providing of training, namely, medical training and teaching in the field of cognitive functions; arranging and conducting educational seminars, conferences, symposiums, training workshops and courses in the field of medicine and cognitive function; educational and training services in the fields of medical research and development, science, clinical tests and trials, medical diagnostic techniques, medicine, pharmaceuticals, medical disorders and diseases and their treatment and prevention and the assessment of cognitive function, the aforementioned services provided live and on-line; educational services, namely, arranging and conducting expert forums, provided live and on-line, in the form of educational seminars, conferences, symposia, workshops and courses in the field of medicine; arranging and conducting educational forums, provided live and on-line, featuring experts in the field medical research and development, science, clinical tests, medical diagnostic techniques, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; providing on-line training programs, namely, courses, seminars and workshops in the field of medicine relating to the assessment of cognitive functions; providing on-line, non-downloadable publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, articles, journals, magazines, and teaching and educational textbooks and manuals in the fields of medical research and development, science, clinical tests and trials, medical diagnostic techniques, medicine, pharmaceuticals, medical disorders and diseases and their treatment and prevention as related to cognitive functionsSECTION 8 - CANCELLED—
042Providing temporary use of on-line, non-downloadable software, namely, computerized screening tools for the assessment of cognitive functionsSECTION 8 - CANCELLED—
044Medical and therapeutic and healthcare services, namely, clinical healthcare services; providing medical and health care information; clinical therapy services, namely, psychiatric services and psychological counseling for the treatment of central nervous system diseases and disorders; pharmaceutical advice; providing medical information regarding medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing medical and medicinal information in the field of diagnostic, medicine, pharmaceuticals, disorders, diseases, and their treatment and prevention; providing on-line medical data and analyses designed to provide patients and clients customized information regarding medical dosage, diagnosis, therapeutic issues and medical managementSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 19, 2024C8..CANCELLED SEC. 8 (6-YR)—
Oct 3, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 3, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 18, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 18, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 15, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 5, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 5, 2017ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jun 2, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 2, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jun 2, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 2, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 2, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 5, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 5, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 5, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 19, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 6, 2016ALIEASSIGNED TO LIE—
Sep 28, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 30, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2016DOCKASSIGNED TO EXAMINER—
Dec 23, 2015MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 22, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance